Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Hepatocellular 4Radiation Injuries 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Melanoma 2Carcinoma 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Meningioma 1Locally Advanced Pancreatic Cancer 1Glioma 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

tremelimumab 1durvalumab 1High-Throughput Nucleotide Sequencing 1Heavy Ion Radiotherapy 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rare Diseases × Heavy Ion Radiotherapy × Clear all
NCT05203250 2025-08-06

Longitudinal Registry Including Patients Treated With Heavy Particles

CNAO National Center of Oncological Hadrontherapy

Recruiting
3,000 enrolled

Neoplasms, Radiation Injuries, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡